Martinez-Serra J - Search Results

1

Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study.

Martin-Broto J, Pousa AL, de Las Peñas R, García Del Muro X, Gutierrez A, Martinez-Trufero J, Cruz J, Alvarez R, Cubedo R, Redondo A, Maurel J, Carrasco JA, López-Martin JA, Sala Á, Meana JA, Ramos R, Martinez-Serra J, Lopez-Guerrero JA, Sevilla I, Balaña C, Vaz Á, De Juan A, Alemany R, Poveda A. Martin-Broto J, et al. Among authors: martinez serra j. J Clin Oncol. 2016 Jul 1;34(19):2294-302. doi: 10.1200/JCO.2015.65.3329. Epub 2016 May 16. J Clin Oncol. 2016. PMID: 27185843 Clinical Trial.

2

Prognostic value of serum CA125 levels in diffuse large B-cell lymphoma: potential role of a new sex- and age-adjusted reference value.

Gutiérrez A, Martínez-Serra J, Barceló B, Sampol A, Viñas L, González G, Bea MD, Amat JC, Martín J, Ramos R, Bautista A, Forteza-Rey J, Rodríguez J, Besalduch J. Gutiérrez A, et al. Int J Lab Hematol. 2010 Dec;32(6 Pt 2):582-9. doi: 10.1111/j.1751-553X.2010.01225.x. Int J Lab Hematol. 2010. PMID: 20201996

3

Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) Study.

Martin-Broto J, Gutierrez A, Garcia-Del-Muro X, Lopez-Guerrero JA, Martinez-Trufero J, de Sande LM, Lainez N, Maurel J, De Juan A, Losa F, Andres R, Casado A, Tejido PG, Blanco R, Carles J, Bellmunt J, Gomez-España A, Ramos R, Martinez-Serra J, Llombart-Bosch A, Poveda A. Martin-Broto J, et al. Ann Oncol. 2010 Jul;21(7):1552-1557. doi: 10.1093/annonc/mdq047. Epub 2010 Mar 15. Ann Oncol. 2010. PMID: 20231303 Free article.

4

Yondelis® (ET-743, Trabectedin) sensitizes cancer cell lines to CD95-mediated cell death: new molecular insight into the mechanism of action.

Martínez-Serra J, Maffiotte E, Martín J, Bex T, Navarro-Palou M, Ros T, Plazas JM, Vögler O, Gutiérrez A, Amat JC, Ramos R, Saus C, Ginés J, Alemany R, Diaz M, Besalduch J. Martínez-Serra J, et al. Eur J Pharmacol. 2011 May 11;658(2-3):57-64. doi: 10.1016/j.ejphar.2011.02.035. Epub 2011 Mar 1. Eur J Pharmacol. 2011. PMID: 21371453

5

Four-channel asymmetric Real-Time PCR hybridization probe assay: a rapid pre-screening method for critical BCR-ABL kinase domain mutations.

Martinez-Serra J, Gutiérrez A, Marcús TF, Soverini S, Amat JC, Navarro-Palou M, Ros T, Bex T, Ballester C, Bauça JM, SanFelix S, Novo A, Vidal C, Santos C, Besalduch J. Martinez-Serra J, et al. Clin Biochem. 2012 Mar;45(4-5):345-51. doi: 10.1016/j.clinbiochem.2011.12.026. Epub 2012 Jan 12. Clin Biochem. 2012. PMID: 22266405

6

Expression of COX-2 on Reed-Sternberg cells is an independent unfavorable prognostic factor in Hodgkin lymphoma treated with ABVD.

Mestre F, Gutierrez A, Ramos R, Martinez-Serra J, Sánchez L, Matheu G, Ros T, Garcia JF, Rodriguez J. Mestre F, et al. Blood. 2012 Jun 21;119(25):6072-9. doi: 10.1182/blood-2011-11-394627. Epub 2012 Apr 30. Blood. 2012. PMID: 22547578 Free article.

7

Nilotinib counteracts P-glycoprotein-mediated multidrug resistance and synergizes the antitumoral effect of doxorubicin in soft tissue sarcomas.

Villar VH, Vögler O, Martínez-Serra J, Ramos R, Calabuig-Fariñas S, Gutiérrez A, Barceló F, Martín-Broto J, Alemany R. Villar VH, et al. PLoS One. 2012;7(5):e37735. doi: 10.1371/journal.pone.0037735. Epub 2012 May 25. PLoS One. 2012. PMID: 22662203 Free PMC article.

8

Oleanolic and maslinic acid sensitize soft tissue sarcoma cells to doxorubicin by inhibiting the multidrug resistance protein MRP-1, but not P-glycoprotein.

Villar VH, Vögler O, Barceló F, Gómez-Florit M, Martínez-Serra J, Obrador-Hevia A, Martín-Broto J, Ruiz-Gutiérrez V, Alemany R. Villar VH, et al. J Nutr Biochem. 2014 Apr;25(4):429-38. doi: 10.1016/j.jnutbio.2013.12.003. Epub 2013 Dec 31. J Nutr Biochem. 2014. PMID: 24491315

9

xCELLigence system for real-time label-free monitoring of growth and viability of cell lines from hematological malignancies.

Martinez-Serra J, Gutierrez A, Muñoz-Capó S, Navarro-Palou M, Ros T, Amat JC, Lopez B, Marcus TF, Fueyo L, Suquia AG, Gines J, Rubio F, Ramos R, Besalduch J. Martinez-Serra J, et al. Onco Targets Ther. 2014 Jun 12;7:985-94. doi: 10.2147/OTT.S62887. eCollection 2014. Onco Targets Ther. 2014. PMID: 24959085 Free PMC article.

10

Fluorescence resonance energy transfer-based real-time polymerase chain reaction method without DNA extraction for the genotyping of F5, F2, F12, MTHFR, and HFE.

Martinez-Serra J, Robles J, Nicolàs A, Gutierrez A, Ros T, Amat JC, Alemany R, Vögler O, Abelló A, Noguera A, Besalduch J. Martinez-Serra J, et al. J Blood Med. 2014 Jun 25;5:99-106. doi: 10.2147/JBM.S64976. eCollection 2014. J Blood Med. 2014. PMID: 25028568 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page